Nuclear paraspeckle assembly transcript 1: The long non-cognized RNA connecting senescence and hepatocellular carcinoma

Yanjun Wu; Han Zhou; Qimin Zhou; Yi Xu

doi:10.1002/ctd2.262

PDF

Clinical and Translational Discovery ›› 2024, Vol. 4 ›› Issue (1) : e262. DOI: 10.1002/ctd2.262

COMMENTARY

Nuclear paraspeckle assembly transcript 1: The long non-cognized RNA connecting senescence and hepatocellular carcinoma

Yanjun Wu¹ ,
Han Zhou²^,³^,⁴ ,
Qimin Zhou⁵ ,
Yi Xu¹

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Yanjun Wu, Han Zhou, Qimin Zhou, Yi Xu. Nuclear paraspeckle assembly transcript 1: The long non-cognized RNA connecting senescence and hepatocellular carcinoma. Clinical and Translational Discovery, 2024, 4(1): e262 https://doi.org/10.1002/ctd2.262

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.

[2]	Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345-1362.

[3]	Llovet JM, Montal R, Sia D, Finn RS. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. 2018;15(10):599-616.

[4]	Cai X, Guillot A, Liu H. Cellular senescence in hepatocellular carcinoma: the passenger or the driver? Cells. 2022;12(1):132.

[5]	Wang B, Demaria M. The quest to define and target cellular senescence in cancer. Cancer Res. 2021;81(24):6087-6089.

[6]	Wang X, Ma L, Pei X, et al. Comprehensive assessment of cellular senescence in the tumor microenvironment. Brief Bioinform. 2022;23(3):bbac118.

[7]	Wang L, Lankhorst L, Bernards R. Exploiting senescence for the treatment of cancer. Nat Rev Cancer. 2022;22(6):340-355.

[8]	Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99-118.

[9]	Huang Z, Zhou JK, Peng Y, He W, Huang C. The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer. 2020;19(1):77.

[10]	Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21(11):1253-1261.

[11]	Mattick JS, Amaral PP, Carninci P, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430-447.

[12]	Chen D, Wang J, Li Y, et al. LncRNA NEAT1 suppresses cellular senescence in hepatocellular carcinoma via KIF11-dependent repression of CDKN2A. Clin Transl Med. 2023;13(9):e1418.

[13]	Zhang P, Cao L, Zhou R, Yang X, Wu M. The lncRNA Neat1 promotes activation of inflammasomes in macrophages. Nat Commun. 2019;10(1):1495.

[14]	Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2):e202009045.

[15]	Prasanna PG, Citrin DE, Hildesheim J, et al. Therapy-induced senescence: opportunities to improve anticancer therapy. J Natl Cancer Inst. 2021;113(10):1285-1298.

[16]	Wang C, Vegna S, Jin H, et al. Inducing and exploiting vulnerabilities for the treatment of liver cancer. Nature. 2019;574(7777):268-272.

RIGHTS & PERMISSIONS

2024 2024 The Authors. Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.